Medicinal Products under the Drug Program B.5, B.6, B.65 and B.163 - 3 Packages Tender

Procurement Summary

Country : Poland

Summary : Medicinal Products under the Drug Program B.5, B.6, B.65 and B.163 - 3 Packages

Deadline : 24 Jul 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 120686859

Document Ref. No. : 377574-2025

Financier : Other Funding Agencies

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Medicinal products under the drug program B.5, B.6, B.65 and B.163 - 3 packages

Treatment of patients with acute leukemia

Lymphoblastic

TebentaFuSpum

concentrate for the preparation of the solution for infusion, 100 / 0.5 ml op./0 vials. EAN in the MZ announcement for the drug program

B.163.fm. Treatment of patients with black hemangioma

Durvalumab

- durvalumab 50 mg/ml 2.4 ml x 1 vial

- durvalumab 50 mg/ml 10 ml x 1 vial

EAN in the MZ announcement for the program Medicine b.5. Treatment of cancer patients

Hepatic cell or bile ducts B.6. Treatment of patients with lung cancer

And pleural miracle

DOC Title: Medicinal products under the drug program B.5, B.6, B.65 and B.163 - 3 Packages

Contract Type: supplies
Document Type: Contract Notice
Reference number: DZP/109/2025
Contract Type: Supplyies
Authority Type: EU-INS-BOD-AG
DOC Title: Medicinal products under the drug program B.5, B.6, B.65 and B.163 - 3 Packages
Dispatch Date: 2025-06-10
Publish Date: 2025-06-11
Submission date: 2025-07-24

Documents

 Tender Notice